Výsledky vyhledávání - "Cindy Kramer"

Autor: Kathy Hogan Edwards, Amanda Littleton, Molly Schneider, Henning Schade, Cindy Kramer, Milos N. Budisavljevic, Yubin Kang, Saurabh Chhabra, Coleen Butcher, Robert K. Stuart, Luciano J. Costa

Publikováno v: Transfusion. 54:3131-3137

Background Compared with growth factor (G) alone, the combination of G with plerixafor (G + P) increases peripheral blood CD34+ count (PB-CD34+) and improves CD34+ collection yield (yCD34+) in multiple myeloma and lymphoma patients undergoing autolog

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5b8d58dcd5cc804a233bd87415f76cb3
https://doi.org/10.1111/trf.12761

Zobrazit plný text záznamu

Prediction of Poor Mobilization of Autologous CD34+ Cells with Growth Factor in Multiple Myeloma Patients: Implications for Risk-Stratification

Autor: Morie A. Gertz, Shaji Kumar, Elizabeth J. Nista, Angela Dispenzieri, Martha Q. Lacy, Yubin Kang, Kathy Hogan Edwards, Luciano J. Costa, Cindy Kramer, Robert K. Stuart, Francis K. Buadi

Publikováno v: Biology of Blood and Marrow Transplantation. 20:222-228

It is unknown whether clinical characteristics can successfully predict which multiple myeloma (MM) patients would be poor mobilizers with growth factor (GF) alone so they can be assigned to mobilization with chemotherapy + GF or GF + plerixafor. MM

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5b5e6cf79412eb0117428ea4f190b81
https://doi.org/10.1016/j.bbmt.2013.11.003

Zobrazit plný text záznamu

Growth factor plus preemptive (‘just-in-time’) plerixafor successfully mobilizes hematopoietic stem cells in multiple myeloma patients despite prior lenalidomide exposure

Autor: Jonathan A Abbas, K.R. Hogan, Yubin Kang, Colleen Butcher, K McDonald, Amanda Littleton, Cindy Kramer, Luciano J. Costa, Katie B Shoptaw, Robert K. Stuart

Publikováno v: Bone Marrow Transplantation. 47:1403-1408

Lenalidomide is associated with suboptimal autologous hematopoietic stem cell (AHSC) mobilization. We hypothesized that growth factor plus preemptive plerixafor is an effective strategy for AHSC mobilization in multiple myeloma (MM) despite prior exp

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab22a79e27fa3984152a6a463ec36899
https://doi.org/10.1038/bmt.2012.60

Zobrazit plný text záznamu

Pegfilgrastim- versus filgrastim-based autologous hematopoietic stem cell mobilization in the setting of preemptive use of plerixafor: efficacy and cost analysis

Autor: Coleen Butcher, Katie B Shoptaw, Robert K. Stuart, Yubin Kang, K.R. Hogan, Luciano J. Costa, Amanda Littleton, Cindy Kramer

Publikováno v: Transfusion. 52:2375-2381

BACKGROUND: Plerixafor enhances the ability of filgrastim (FIL) to mobilize CD34+ cells but adds cost to the mobilization. We hypothesized that replacing weight-based FIL with flat-dose pegfilgrastim (PEG) in a validated cost-based mobilization algor

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8ec514779322c3524008679b92c5692e
https://doi.org/10.1111/j.1537-2995.2012.03579.x

Zobrazit plný text záznamu

Efficacy and Safety of Ciprofloxacin for Prophylaxis of Polyomavirus BK Virus–Associated Hemorrhagic Cystitis in Allogeneic Hematopoietic Stem Cell Transplantation Recipients

Autor: C. Schaub, K.R. Hogan, Robert K. Stuart, Luciano J. Costa, Cindy Kramer, Ashley N. Miller, Ashley E. Glode

Publikováno v: Biology of Blood and Marrow Transplantation. 17(8):1176-1181

Polyoma virus BK-induced hemorrhagic cystitis is an important cause of morbidity after hematopoietic stem cell transplantation (HSCT). Fluoroquinolones have been shown in vitro to inhibit BK viral replication by direct inhibition of the BK-encoded DN

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8189e9450902703ab5183b2580528e4f

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání